查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1411377

抗毒素市場：按類型分類，2024-2030 年全球預測

Antivenoms Market by Species (Scorpion, Snakes, Spiders), Type (Monovalent Antivenom, Polyvalent Antivenom) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年抗毒素市場規模為26.9億美元，預計2024年將達28.7億美元，2030年將達43.7億美元，複合年成長率為7.17%。

全球抗毒素市場

主要市場統計
基準年[2023] 26.9億美元
預測年份 [2024] 28.7億美元
預測年份 [2030] 43.7億美元
複合年成長率（%） 7.17%
抗毒素市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估抗蛇毒血清市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對抗蛇毒血清市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場並分析其在成熟細分市場的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-抗毒素市場的市場規模和預測是多少？

2-抗毒素市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3-抗毒素市場的技術趨勢和法律規範是什麼？

4-抗毒素市場主要供應商的市場佔有率是多少？

5-進入抗毒素市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 蛇咬傷事件增加
      • 提高對可用作急救治療的抗蛇毒血清的認知
      • 農村醫療衛生基礎設施不斷完善
    • 抑制因素
      • 抗蛇毒血清生產成本高
    • 機會
      • 抗毒素生產技術進步
      • 改善各國抗毒素的經銷網路
    • 任務
      • 缺乏抗蛇毒血清生產的監管標準
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 抗毒素市場：類型

  • 蠍
  • 蛇
  • 蜘蛛

第7章抗毒素市場：依類型

  • 單價抗毒素
  • 多效價抗毒素

第8章美洲抗毒素市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太抗毒素市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲抗毒素市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第12章競爭產品組合

  • 主要公司簡介
    • Amsaal LLC
    • BB-NCIPD Ltd.
    • Bharat Serums and Vaccines Limited（BSV）
    • Boehringer Ingelheim International GmbH.
    • BTG International Inc.
    • Creative BioMart
    • CSL
    • Haffkine Bio-Pharmaceutical Corporation Ltd.
    • Incepta Pharma
    • Inosan Biopharma
    • Institute of Vaccines and Medical Biologicals
    • Instituto Clodomiro Picado
    • KM Biologics
    • Laboratorios Silanes, SA de CV
    • Lexicare Pharma Pvt. Ltd.
    • Medtoxin Venom Laboratories, LLC
    • Merck & Co., Inc.
    • MicroPharm
    • Padula Serums Pty Ltd.
    • Pfizer Inc.
    • Rare Disease Therapeutics, Inc.
    • Serum Institute of India Pvt. Ltd.
    • Shanghai Serum Bio-technology Co., Ltd.
    • VINS Bioproducts Ltd.
  • 主要產品系列

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-C002B1C994B6

[193 Pages Report] The Antivenoms Market size was estimated at USD 2.69 billion in 2023 and expected to reach USD 2.87 billion in 2024, at a CAGR 7.17% to reach USD 4.37 billion by 2030.

Global Antivenoms Market

KEY MARKET STATISTICS
Base Year [2023] USD 2.69 billion
Estimated Year [2024] USD 2.87 billion
Forecast Year [2030] USD 4.37 billion
CAGR (%) 7.17%
Antivenoms Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antivenoms Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antivenoms Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antivenoms Market, highlighting leading vendors and their innovative profiles. These include Amsaal LLC, BB - NCIPD Ltd., Bharat Serums and Vaccines Limited (BSV), Boehringer Ingelheim International GmbH., BTG International Inc., Creative BioMart, CSL, Haffkine Bio-Pharmaceutical Corporation Ltd., Incepta Pharma, Inosan Biopharma, Institute of Vaccines and Medical Biologicals, Instituto Clodomiro Picado, KM Biologics, Laboratorios Silanes, S.A. de C.V, Lexicare Pharma Pvt. Ltd., Medtoxin Venom Laboratories, LLC, Merck & Co., Inc., MicroPharm, Padula Serums Pty Ltd., Pfizer Inc., Rare Disease Therapeutics, Inc., Serum Institute of India Pvt. Ltd., Shanghai Serum Bio-technology Co., Ltd., and VINS Bioproducts Ltd..

Market Segmentation & Coverage

This research report categorizes the Antivenoms Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Species
    • Scorpion
    • Snakes
    • Spiders
  • Type
    • Monovalent Antivenom
    • Polyvalent Antivenom
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Antivenoms Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antivenoms Market?

3. What are the technology trends and regulatory frameworks in the Antivenoms Market?

4. What is the market share of the leading vendors in the Antivenoms Market?

5. Which modes and strategic moves are suitable for entering the Antivenoms Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Antivenoms Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of snake bites
      • 5.1.1.2. Rising awareness of antivenoms available as first-aid
      • 5.1.1.3. Increasing improvements in healthcare infrastructure in rural areas
    • 5.1.2. Restraints
      • 5.1.2.1. High production cost of antivenoms
    • 5.1.3. Opportunities
      • 5.1.3.1. Technical advancements in antivenoms production
      • 5.1.3.2. Improvement in distribution networks of antivenoms in countries
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of regulatory norms for antivenom manufacturing
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Antivenoms Market, by Species

  • 6.1. Introduction
  • 6.2. Scorpion
  • 6.3. Snakes
  • 6.4. Spiders

7. Antivenoms Market, by Type

  • 7.1. Introduction
  • 7.2. Monovalent Antivenom
  • 7.3. Polyvalent Antivenom

8. Americas Antivenoms Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Antivenoms Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Antivenoms Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Amsaal LLC
    • 12.1.2. BB - NCIPD Ltd.
    • 12.1.3. Bharat Serums and Vaccines Limited (BSV)
    • 12.1.4. Boehringer Ingelheim International GmbH.
    • 12.1.5. BTG International Inc.
    • 12.1.6. Creative BioMart
    • 12.1.7. CSL
    • 12.1.8. Haffkine Bio-Pharmaceutical Corporation Ltd.
    • 12.1.9. Incepta Pharma
    • 12.1.10. Inosan Biopharma
    • 12.1.11. Institute of Vaccines and Medical Biologicals
    • 12.1.12. Instituto Clodomiro Picado
    • 12.1.13. KM Biologics
    • 12.1.14. Laboratorios Silanes, S.A. de C.V
    • 12.1.15. Lexicare Pharma Pvt. Ltd.
    • 12.1.16. Medtoxin Venom Laboratories, LLC
    • 12.1.17. Merck & Co., Inc.
    • 12.1.18. MicroPharm
    • 12.1.19. Padula Serums Pty Ltd.
    • 12.1.20. Pfizer Inc.
    • 12.1.21. Rare Disease Therapeutics, Inc.
    • 12.1.22. Serum Institute of India Pvt. Ltd.
    • 12.1.23. Shanghai Serum Bio-technology Co., Ltd.
    • 12.1.24. VINS Bioproducts Ltd.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ANTIVENOMS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIVENOMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANTIVENOMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTIVENOMS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANTIVENOMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANTIVENOMS MARKET DYNAMICS
  • FIGURE 7. ANTIVENOMS MARKET SIZE, BY SPECIES, 2023 VS 2030 (%)
  • FIGURE 8. ANTIVENOMS MARKET SIZE, BY SPECIES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANTIVENOMS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. ANTIVENOMS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ANTIVENOMS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ANTIVENOMS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANTIVENOMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANTIVENOMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIVENOMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIVENOMS MARKET SIZE, BY SCORPION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTIVENOMS MARKET SIZE, BY SNAKES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTIVENOMS MARKET SIZE, BY SPIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 10. ANTIVENOMS MARKET SIZE, BY MONOVALENT ANTIVENOM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANTIVENOMS MARKET SIZE, BY POLYVALENT ANTIVENOM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ANTIVENOMS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 99. ANTIVENOMS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. ANTIVENOMS MARKET LICENSE & PRICING